omega-n-methylarginine has been researched along with vardenafil dihydrochloride in 1 studies
Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (vardenafil dihydrochloride) | Trials (vardenafil dihydrochloride) | Recent Studies (post-2010) (vardenafil dihydrochloride) |
---|---|---|---|---|---|
4,411 | 344 | 336 | 780 | 151 | 289 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brand, M; Deussen, A | 1 |
1 other study(ies) available for omega-n-methylarginine and vardenafil dihydrochloride
Article | Year |
---|---|
Vardenafil increases coronary flow response to hypercapnic acidosis in isolated guinea pig heart.
Topics: Acidosis; Animals; Coronary Circulation; Cromakalim; Cyclic GMP; Dose-Response Relationship, Drug; Guinea Pigs; Hypercapnia; Imidazoles; In Vitro Techniques; Male; Nitric Oxide; omega-N-Methylarginine; Phosphodiesterase Inhibitors; Piperazines; Signal Transduction; Sulfones; Triazines; Vardenafil Dihydrochloride; Vasodilation | 2007 |